Get started
Author

Ingrid DuRand

Mapping the human genetic architecture of COVID-19
2021 · COVID-19 Host Genetics Initiative, COVID-19 Host Genetics InitiativeLeadership, et al. · Nature · 997
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 562
PDF
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 508
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 393
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
2021 · Clark D Russell, Cameron J Fairfield, et al. · The Lancet Microbe · 365
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 354
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 302
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
2021 · Ryan S Thwaites, Ashley Sanchez Sevilla Uruchurtu, et al. · Science Immunology · 228
Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
2021 · Rishi K Gupta, Ewen M Harrison, et al. · The Lancet Respiratory Medicine · 223
PDF
Adeno-associated virus 2 infection in children with non-A–E hepatitis
2023 · Antonia Ho, Richard Orton, et al. · Nature · 200
PDF
Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
2021 · Chloe I Bloom, Thomas M Drake, et al. · The Lancet Respiratory Medicine · 182
PDF
Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study
2021 · Thomas M Drake, Aya M Riad, et al. · The Lancet · 161
PDF
Genomic investigations of unexplained acute hepatitis in children
2023 · Sofia Morfopoulou, Sarah Buddle, et al. · Nature · 157
PDF
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 139
Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK
2021 · Annemarie B Docherty, Rachel H Mulholland, et al. · The Lancet Respiratory Medicine · 125
PDF
SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
2022 · Felicity Liew, Shubha Talwar, et al. · EBioMedicine · 120
Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease
2024 · Felicity Liew, Claudia Efstathiou, et al. · Nature Immunology · 119
PDF
Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: a prospective, multicentre cohort study
2021 · Michael K Sullivan, Jennifer S Lees, et al. · Nephrology Dialysis Transplantation · 99
PDF
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
2021 · Thushan I. de Silva, Guihai Liu, et al. · iScience · 90
PDF
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
2021 · Thomas M Drake, Cameron J Fairfield, et al. · The Lancet Rheumatology · 74
PDF
Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses
2023 · Benedict D. Michael, Cordelia Dunai, et al. · Nature Communications · 51
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 41
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41
PDF
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
2021 · Quentin J. Leclerc, Naomi M. Fuller, et al. · BMC Health Services Research · 40
PDF
The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection
2023 · Hannah Goldswain, Xiaofeng Dong, et al. · Genome biology · 39
PDF
Works count: 37
Citation count: 5,747
H-index: 27
I10-index: 30
Year
Topic
Type